Health Care · Health Care Equipment

PROCEPT BioRobotics Corporation PRCT

$18.08+0.39 (+2.20%)delayed quote · as of 2026-07-29 01:11 UTC

Open PRCT in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$1.0B

Previous close

$17.69

Volume

1.4M

52-week range

$16.67 – $55.32

Verdictconfidence 75% · moderate

Caution flags on quality, health and momentum.

1 of 5 dimensions score well; quality, health and momentum flash caution. Value not scored — not enough data.

Value—0/1 checks

Growth672/3 checks

Quality00/3 checks

Health331/3 checks

Momentum00/5 checks

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

—

P/E FWD

—

EV/EBITDA TTM

—

PEG

—

Growth

Revenue 3y

+60.1%/yr

Revenue YoY

+37.2%

Expected EPS

—

Quality

ROE

-26.1%

Quality checks

bank measures

Health

Equity/assets

72.0%

Solvency score

n/a for financials

Momentum

vs 50-day

−31.6%

vs 200-day

−49.5%

52-wk range

FY 2025: revenue $308.1M · net income $-95,572,000 · free cash flow $-58,341,000 (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-29 01:11 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading PRCT’s filed statements…

Continue with PRCT in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.